United Kingdom
  • Europe
    • FR
    • DE
    • IT
    • ES
    • NL
    • PL
  • News
  • UK
  • World
  • Business
  • Technology
  • Science
  • Entertainment
  • Sports
  • Health
  • US
  • Africa

Categories

  • Artificial intelligence
  • Arts and design
  • Birmingham
  • Books
  • Boxing
  • Brexit
  • Bristol
  • Britain
  • Business
  • Celebrities
  • Computing
  • Cricket
  • Cycling
  • Economy
  • Edinburgh
  • England
  • Entertainment
  • Entrepreneurship
  • Environment
  • EU
  • F1
  • Fitness
  • Football
  • France
  • Gadgets
  • Genetics
  • Germany
  • Glasgow
  • Golf
  • Health
  • Healthcare
  • Internet
  • Jobs
  • Leeds
  • Liverpool
  • London
  • Manchester
  • Markets
  • Medication
  • Mental health
  • Mobile
  • Movies
  • Music
  • News
  • Northern Ireland
  • Nutrition
  • Personal finance
  • Physics
  • Racing
  • Royals
  • Rugby
  • Russia
  • Science
  • Scotland
  • Sheffield
  • Space
  • Spain
  • Sports
  • Technology
  • Tennis
  • TV
  • UK
  • Ukraine
  • United Kingdom
  • United States
  • Virtual reality
  • Wales
  • Wildlife
  • World
United Kingdom
  • Europe
    • FR
    • DE
    • IT
    • ES
    • NL
    • PL
  • News
  • UK
  • World
  • Business
  • Technology
  • Science
  • Entertainment
  • Sports
  • Health
  • US
  • Africa

Browsing Tag

Vanda Pharmaceuticals Inc.

3 posts
MMedication
Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness
Read More

Vanda Pharmaceuticals Announces Receipt of FDA Decision Letter on HETLIOZ® Supplemental New Drug Application for Jet Lag Disorder

  • 8 January 2026
WASHINGTON, Jan. 8, 2026 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it has received…
MMedication
Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness
Read More

Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness

  • 29 November 2025
FDA requests, and Vanda agrees to, a brief extension (to December 5, 2025) for the expedited re-review of…
MMedication
FDA Bureaucrats Unlawfully Delay Hearing on Vanda Drug and Falsely Blame Commissioner Makary and the reductions in force at FDA
Read More

FDA Bureaucrats Unlawfully Delay Hearing on Vanda Drug and Falsely Blame Commissioner Makary and the reductions in force at FDA

  • 24 April 2025
WASHINGTON, April 23, 2025 /PRNewswire/ — Vanda Pharmaceuticals Inc. (“Vanda”) (Nasdaq: VNDA) today announced that FDA bureaucrats have committed…
United Kingdom
www.europesays.com